Edition:
United Kingdom

Cardiome Pharma Corp (CRME.OQ)

CRME.OQ on NASDAQ Stock Exchange Capital Market

1.54USD
19 Jan 2018
Change (% chg)

$0.01 (+0.65%)
Prev Close
$1.53
Open
$1.55
Day's High
$1.56
Day's Low
$1.53
Volume
10,394
Avg. Vol
20,002
52-wk High
$4.83
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 6.02 -0.196
Jun '17 5.75 -0.262
Mar '17 5.20 -0.199
FY 2016 Dec '16 7.02 -0.175
Sep '16 5.24 -0.186
Jun '16 5.91 -0.369
Mar '16 7.09 -0.061
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 7.49 8.40 6.88 --
Quarter Ending Jun-18 3 8.54 9.00 8.30 --
Year Ending Dec-18 5 38.91 47.62 32.28 44.33
Earnings (per share)
Quarter Ending Mar-18 3 -0.21 -0.17 -0.23 --
Quarter Ending Jun-18 3 -0.19 -0.17 -0.21 --
Year Ending Dec-18 5 -0.51 0.10 -0.89 -0.27
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. 16.88 40.98 46.03
P/E Low - Last 5 Yrs. 16.88 23.80 24.39
Beta 0.96 0.90 0.89
Price to Sales (TTM) 2.91 3.98 5.45
Price to Book (MRQ) 2.39 4.82 5.38
Price to Tangible Book (MRQ) 13.98 5.57 6.89
Price to Cash Flow (TTM) -- 23.02 23.43
% Owned Institutions 76.58 1.23 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) -- 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -2.66 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago 2.35 4.69 5.44
Sales - 5 Yr. Growth Rate 75.78 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 28.91 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago 25.69 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate 68.00 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.12 2.11 2.18
Current Ratio (MRQ) 4.81 2.88 2.97
LT Debt to Equity (MRQ) 98.56 9.81 12.10
Total Debt to Equity (MRQ) 98.56 13.80 16.38
Interest Coverage (TTM) -6.89 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.75 55.13 54.76
Gross Margin - 5 Yr. Avg. -- 52.41 52.45
EBITD Margin (TTM) -74.55 -- --
EBITD - 5 Yr. Avg -90.65 18.54 15.33
Operating Margin (TTM) -89.61 14.40 7.60
Operating Margin - 5 Yr. Avg. -80.02 14.46 10.79
Pre-Tax Margin (TTM) -110.61 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. -92.70 14.77 11.19
Net Profit Margin (TTM) -110.81 11.09 4.70
Net Profit Margin - 5 Yr. Avg. -93.06 11.11 7.50
Effective Tax Rate (TTM) -- 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. -- 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 193,400 948,195,516 855,725,045
Net Income/Employee (TTM) -214,300 111,561,295 100,665,187
Receivable Turnover (TTM) 3.61 5.61 5.76
Inventory Turnover (TTM) 1.21 2.57 3.34
Asset Turnover (TTM) 0.37 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.66 11.41 10.97
Return on Assets - 5 Yr. Avg. -30.22 12.98 12.39
Return on Investment (TTM) -53.51 14.84 14.40
Return on Investment - 5 Yr. Avg. -49.19 16.97 16.20
Return on Equity (TTM) -123.49 16.32 16.09
Return on Equity - 5 Yr. Avg. -78.01 18.05 17.53
  1 Year 3 Year 5 Year
Sales % 20.78 77.57 75.78
EPS (TTM) % 42.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cardiome Pharma Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.